Ulipristal acetate

Details

Files

Generic Name:

Ulipristal acetate

Project Status:

Complete

Therapeutic Area:

Uterine fibroids

Manufacturer:

Actavis Specialty Pharmaceuticals Co.

Call for patient/clinician input open:

April 15, 2013

Brand Name:

Fibristal

Project Line:

Reimbursement Review

Project Number:

SR0326-000

Call for patient/clinician input closed:

May 9, 2013

NOC Status at Filing:

Pre NOC

Submission Type:

Initial

Indications:

Uterine fibroids (signs and symptoms)

Recommendation Type:

List with criteria/condition

Final Recommendation:

November 15, 2013

Files

Submission Status Report View PDF

Clinical Report View PDF

Pharmacoeconomic Report View PDF

Recommendation and Reasons View PDF

Last Updated : April 17, 2013